304 related articles for article (PubMed ID: 24515801)
1. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells.
Lee SO; Jin UH; Kang JH; Kim SB; Guthrie AS; Sreevalsan S; Lee JS; Safe S
Mol Cancer Res; 2014 Apr; 12(4):527-538. PubMed ID: 24515801
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.
Lee SO; Abdelrahim M; Yoon K; Chintharlapalli S; Papineni S; Kim K; Wang H; Safe S
Cancer Res; 2010 Sep; 70(17):6824-36. PubMed ID: 20660371
[TBL] [Abstract][Full Text] [Related]
3. The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists.
Hedrick E; Lee SO; Safe S
Mol Carcinog; 2017 Sep; 56(9):2066-2075. PubMed ID: 28418095
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).
Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S
Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in Rhabdomyosarcoma.
Hedrick E; Mohankumar K; Lacey A; Safe S
Mol Cancer Res; 2019 Nov; 17(11):2221-2232. PubMed ID: 31462501
[TBL] [Abstract][Full Text] [Related]
6. Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy.
Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
Endocr Relat Cancer; 2015 Oct; 22(5):831-40. PubMed ID: 26229035
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.
Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S
Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma.
Hedrick E; Lee SO; Kim G; Abdelrahim M; Jin UH; Safe S; Abudayyeh A
PLoS One; 2015; 10(6):e0128308. PubMed ID: 26035713
[TBL] [Abstract][Full Text] [Related]
9. Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.
Lee SO; Li X; Hedrick E; Jin UH; Tjalkens RB; Backos DS; Li L; Zhang Y; Wu Q; Safe S
Mol Endocrinol; 2014 Oct; 28(10):1729-39. PubMed ID: 25099012
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the orphan nuclear receptor NR4A1 contributes to apoptosis induction by fangchinoline in pancreatic cancer cells.
Lee HS; Safe S; Lee SO
Toxicol Appl Pharmacol; 2017 Oct; 332():32-39. PubMed ID: 28754437
[TBL] [Abstract][Full Text] [Related]
11. Broussochalcone A Is a Novel Inhibitor of the Orphan Nuclear Receptor NR4A1 and Induces Apoptosis in Pancreatic Cancer Cells.
Lee HS; Kim SH; Kim BM; Safe S; Lee SO
Molecules; 2021 Apr; 26(8):. PubMed ID: 33923503
[TBL] [Abstract][Full Text] [Related]
12. Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis.
Mohankumar K; Li X; Sung N; Cho YJ; Han SJ; Safe S
Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32099996
[TBL] [Abstract][Full Text] [Related]
13. Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors.
Yoon K; Lee SO; Cho SD; Kim K; Khan S; Safe S
Carcinogenesis; 2011 Jun; 32(6):836-42. PubMed ID: 21362629
[TBL] [Abstract][Full Text] [Related]
14. Targeting NR4A1 (TR3) in cancer cells and tumors.
Lee SO; Li X; Khan S; Safe S
Expert Opin Ther Targets; 2011 Feb; 15(2):195-206. PubMed ID: 21204731
[TBL] [Abstract][Full Text] [Related]
15. The Orphan Nuclear Receptor NR4A1 Protects Pancreatic β-Cells from Endoplasmic Reticulum (ER) Stress-mediated Apoptosis.
Yu C; Cui S; Zong C; Gao W; Xu T; Gao P; Chen J; Qin D; Guan Q; Liu Y; Fu Y; Li X; Wang X
J Biol Chem; 2015 Aug; 290(34):20687-20699. PubMed ID: 26157144
[TBL] [Abstract][Full Text] [Related]
16. p21 expression is induced by activation of nuclear nerve growth factor-induced Balpha (Nur77) in pancreatic cancer cells.
Lee SO; Chintharlapalli S; Liu S; Papineni S; Cho SD; Yoon K; Safe S
Mol Cancer Res; 2009 Jul; 7(7):1169-78. PubMed ID: 19584258
[TBL] [Abstract][Full Text] [Related]
17. NR4A1 counteracts JNK activation incurred by ER stress or ROS in pancreatic β-cells for protection.
Pu ZQ; Liu D; Lobo Mouguegue HPP; Jin CW; Sadiq E; Qin DD; Yu TF; Zong C; Chen JC; Zhao RX; Lin JY; Cheng J; Yu X; Li X; Zhang YC; Liu YT; Guan QB; Wang XD
J Cell Mol Med; 2020 Dec; 24(24):14171-14183. PubMed ID: 33124187
[TBL] [Abstract][Full Text] [Related]
18. The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53.
Lee SO; Andey T; Jin UH; Kim K; Singh M; Safe S
Oncogene; 2012 Jul; 31(27):3265-76. PubMed ID: 22081070
[TBL] [Abstract][Full Text] [Related]
19. NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.
Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
Mol Cell Biol; 2016 May; 36(9):1383-94. PubMed ID: 26929200
[TBL] [Abstract][Full Text] [Related]
20. Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer.
Mohankumar K; Li X; Sridharan S; Karki K; Safe S
Gynecol Oncol; 2019 Jul; 154(1):218-227. PubMed ID: 31053403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
